Evolutionary Genomics, Inc.

OTCPK:FNAM Stock Report

Market Cap: US$5.3k

Evolutionary Genomics Balance Sheet Health

Financial Health criteria checks 0/6

Insufficient data to determine the health of Evolutionary Genomics

Key information

n/a

Debt to equity ratio

n/a

Debt

Interest coverage ration/a
Cashn/a
Equityn/a
Total liabilitiesn/a
Total assetsn/a

Recent financial health updates

Recent updates

Financial Position Analysis

Short Term Liabilities: Insufficient data to determine if FNAM's short term assets cover its short term liabilities.

Long Term Liabilities: Insufficient data to determine if FNAM's short term assets cover its long term liabilities.


Debt to Equity History and Analysis

Debt Level: Insufficient data to calculate FNAM's net debt to equity ratio to determine if it is satisfactory.

Reducing Debt: Insufficient data to determine if FNAM's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: Insufficient data to determine if FNAM's debt is well covered by operating cash flow.

Interest Coverage: Insufficient data to determine if FNAM's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies